161 results
Page 2 of 9
8-K
EX-99.2
xeqqvbhem i4
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
0eoaopy7dw mwj8
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
1dmil6 2ta
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.1
lr6tr
14 Aug 23
Other Events
8:00am
8-K
EX-99.1
odnw 3p7ljozq
10 Aug 23
Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
7:03am
8-K
EX-99.2
v7o0zdlhu v5rtzv
25 Jul 23
Top-line safety, pharmacokinetic, and pharmacodynamic (frataxin level) data from Phase 2 trial’s 50 mg cohort expected in 1H 2024
7:02am
8-K
EX-99.1
h0koivmm5 254a
25 Jul 23
Top-line safety, pharmacokinetic, and pharmacodynamic (frataxin level) data from Phase 2 trial’s 50 mg cohort expected in 1H 2024
7:02am
8-K
EX-99.1
miwk5xh19c 9drwh
17 Jul 23
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
4:08pm
8-K
EX-99.1
sfl3f6zv txg29j7
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
obrtc92q8g eekhdkcqw
15 May 23
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
8ohgdnmilsi
15 May 23
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
qb64n7gws
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
8q9j8drca2g 906
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am